STAA Staar Surgical Co OPHTHALMIC GOODS Best Medical Devices Stocks 2026 →

Staar Surgical (STAA) Stock: Buy, Sell, or Hold?

$26.78
+0.09 (+0.34%) ▲
5d: +0.22% 30d: +22.62% 90d: +2.29%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (45%)
Quality Score
39/100
Position
FAIR
30-Day Fair Range
$21.71 – $24.92
Position: FAIR
Forward P/E & Valuation
23.2x CHEAP
vs 34.7x historical avg
Wall Street Target
$28.56
+6.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$23.26 / $29.57
Trend: Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
ℹī¸ NEUTRAL: STAA is fairly priced but lacks strong directional signals. At -12.7% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.

Get Alerted When STAA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$43.19
Based on 8.4% avg growth
INTRINSIC VALUE TODAY
$26.82
0.1% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: STAA is currently trading at $26.78, which is considered fair relative to its 30-day fair value range of $21.71 to $24.92. From a valuation perspective, the stock is trading at a discount (Forward PE: 23.1) compared to its historical average (34.7). Remarkably, the market is currently pricing in an annual earnings decline of 12.7% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, STAA is in a downtrend. Immediate support is located at $23.26, while resistance sits at $29.57.

Market Sentiment: STAA scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $21.71 - $24.92
Company Quality Score 39/100 (SELL)
Volume Confirmation HIGH
Confidence Score 45.2%

Trading Range & Key Levels

30-Day Trading Range $21.71 - $24.92
Current vs Trading Range FAIR
Support Level $23.26
Resistance Level $29.57
Current Trend Downtrend
Technical data as of Nov 12, 2026

Protect Your Profits

Holding STAA? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BEARISH: Weak technical setup (32/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($28.56)
  • WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 23.15
Wall Street Target $28.56 (+6.6%)
Revenue Growth (YoY) -12.0%
Earnings Growth (YoY) -38.5%
Profit Margin 0.2%
Valuation Discount vs History -12.7% cheaper
PE vs Historical 23.2 vs 34.7 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -12.7% (market-implied from PE analysis)
1-Year Target $24.10 (-10%)
2-Year Target $21.69 (-19%)
3-Year Target $19.52 (-27%)
3-Yr Target (if PE normalizes) (PE: 23→35) $29.26 (+9%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 23.2, Growth: 12.8%) $38.49 (+44%)
Base: (SPY PE: 19.9, Growth: 12.8%) $33.01 (+23%)
Bear: (PE: 16.9, Growth: 12.8%) $28.06 (+5%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (43x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Forward PE: 42.55 | Forward EPS (Implied): $0.63
Bull Case $32.34 (+21%)
Analyst growth 15.0%, PE expands to 44.7
Base Case $26.78 (0%)
Market implied 0.0%, PE stable at 42.6
Bear Case $20.49 (-24%)
Severe decline -15.0%, PE contracts to 38.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 23.2 to 34.7
Stabilization Target: $40.14 (+49.9%)
PE Expansion Potential: +49.9%
Share STAA Analysis

Share this live STAA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

Reddit StockTwits X / Twitter
bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (STAA)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary: Staar Surgical reported record nine-month revenue, driven by strong sales growth in China and ex-China markets, as well as improved profitability.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 6:24 PM ET
Data refreshes hourly during market hours. Next update: 7:24 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
See Full Scanner Results »
Technical Signals Check

Is STAA showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for STAA.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ISRG
Intuitive Surgical Inc 		STRONG BUY
34 analysts 		$486 39 SELL
ALC
Alcon AG 		STRONG BUY
27 analysts 		$82 44 HOLD
RGEN
Repligen Corporation 		STRONG BUY
21 analysts 		$203 55 HOLD
WST
West Pharmaceutical Servâ€Ļ 		STRONG BUY
16 analysts 		$471 42 HOLD
RMD
ResMed Inc 		HOLD
20 analysts 		$264 58 HOLD
ISRG Intuitive Surgicaâ€Ļ
39 SELL
ALC Alcon AG
44 HOLD
RGEN Repligen Corporatâ€Ļ
55 HOLD
WST West Pharmaceuticâ€Ļ
42 HOLD
RMD ResMed Inc
58 HOLD

Advanced STAA Option Strategies

Professional options setups generated by AI based on today's STAA price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive STAA Research Pages
STAA Technical Chart STAA Price Prediction STAA Intrinsic Value DCF STAA Earnings Date STAA Investment Advisor STAA Fair Price Analyzer STAA Options Chain STAA Options Advisor STAA Options Analysis STAA Competitors
Part B: Tradestie Flagship Market Scanners
Today's Best Signals (STAA) Sector Rotation Monitor AI Supply Chain Money Flow Gamma Squeeze (GEX) Scanner Undervalued Stocks Scanner Insider Cluster Buying Reddit & WSB Sentiment Tracker Backtested Stock Scanner
Compare STAA with Peers
STAA vs RGEN
Which one to buy?
STAA vs BL
Which one to buy?
STAA vs QDEL
Which one to buy?
STAA vs PODD
Which one to buy?
STAA vs IRTC
Which one to buy?
STAA vs PODD
Winner: STAA
STAA vs NVCR
Winner: STAA
PLSE vs STAA
Winner: STAA
SMTI vs STAA
SLP vs STAA
LMAT vs STAA
STAA vs NNNN
STAA vs QDEL
EMBC vs STAA
Winner: EMBC
MLSS vs STAA
Create New Comparison View All Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals